NCT04509115View on ClinicalTrials.gov

Variation in Opioid Prescribing and Use for Acute Pain in Diverse Populations

CompletedOBSERVATIONAL

Enrollment

1,709

Participants

Timeline

Start Date

September 11, 2020

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions

Opioid UseOpioid Prescribing

Interventions

DRUG

Short-acting opioid prescription for acute pain

Patients not currently using opioids who receive a new short-acting opioid prescription as part of routine care for acute pain will be recruited and followed prospectively for 180 days.

Trial Locations (5)

35233

University of Alabama Birmingham, Birmingham

55905

Mayo Clinic, Rochester

57701

Monument Health, Rapid City

90048

Cedars Sinai, Los Angeles

06510

Yale-New Haven Health, New Haven

All Listed Sponsors

collaborator

Food and Drug Administration (FDA)

FED

lead

Yale University

OTHER

NCT04509115 - Variation in Opioid Prescribing and Use for Acute Pain in Diverse Populations | Biotech Hunter | Biotech Hunter